Kips Bay Medical (KIPS) 0.0071 $KIPS
Kips Bay Medical Provides Business Update and Reports Second Quarter 2015 Results
GlobeNewswire - Thu Aug 06, 8:04AM CDT
Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company that was focused on manufacturing and commercializing its external saphenous vein support technology, eSVS Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its second quarter ended June 27, 2015.
Kips Bay Medical Announces an Orderly Wind Down of Operations With the Termination of eMESH I Clinical Feasibility Trial
GlobeNewswire - Mon Jun 29, 7:49AM CDT
Kips Bay Medical, Inc. (OTCQB:KIPS) today announced its decision to terminate its eMESH I clinical feasibility trial due to poor early angiographic results from enrolled patients who had an eSVS Mesh implanted using the new surgical implant technique and its intention to effect an orderly wind down of its operations.
Kips Bay Medical Provides Clinical Trial Update and Reports First Quarter 2015 Results
GlobeNewswire - Tue May 12, 3:53PM CDT
Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS Mesh, for use in coronary artery bypass grafting surgery, today provided a clinical trial update and announced financial results for its first quarter ended March 28, 2015.
Kips Bay Medical Announces $3.25 Million Private Placement Bridge Financing
GlobeNewswire - Tue Mar 24, 3:37PM CDT
Investors Include Manny Villafana and Kips Bay Investments, LLC
Kips Bay Medical Announces Achievement of Enrollment Goal and Provides Business Update and Fourth Quarter and Full Year 2014 Results
GlobeNewswire - Thu Mar 12, 8:09AM CDT
Manny Villafana, Chairman and Chief Executive Officer of Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS Mesh, for use in coronary artery bypass grafting surgery, today announced that the Company had reached its targeted enrollment goal for its eMESH I clinical feasibility trial and provided a business update and financial results for its fourth quarter and full year ended December 31, 2014.
Kips Bay Medical Reorganizes Operations and Reduces Staff to Focus on Clinical Study Work and Conserve Capital
GlobeNewswire - Mon Jan 05, 11:00AM CST
Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today announced that the Company has reorganized its operations by eliminating staff positions, instituting salary reductions and reducing its non-clinical related operating expenses, in order to conserve its capital while it pursues the completion of its current eMESH I clinical feasibility trial.
Kips Bay Medical Announces the First eSVS Mesh Implant by the Valley Hospital of New Jersey
GlobeNewswire - Tue Nov 11, 8:23AM CST
Manny Villafana, Chairman and CEO of Kips Bay Medical, Inc. (OTCQB:KIPS), announced that on November 4, 2014, cardiac surgeons at The Valley Hospital's Heart and Vascular Institute in Ridgewood, New Jersey, performed their first implant of an eSVS Mesh. This implant was performed as part of the Kips Bay Medical eMESH I clinical feasibility trial currently being conducted for the U.S. Food and Drug Administration (FDA) in a number of preeminent cardiac surgery centers in both Europe and the United States.
Kips Bay Medical Provides Feasibility Study Update and Reports Third Quarter 2014 Results
GlobeNewswire - Thu Nov 06, 8:45AM CST
Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provided a business update and announced financial results for its third quarter ended September 27, 2014.
Kips Bay Medical Provides Clinical and Business Update
GlobeNewswire - Tue Oct 14, 8:00AM CDT
Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provides an update on its clinical progress and business operations.
Kips Bay Medical Provides Business Update and Reports Second Quarter 2015 Results
GlobeNewswire - Thu Aug 06, 8:04AM CDT
Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company that was focused on manufacturing and commercializing its external saphenous vein support technology, eSVS Mesh, for use in coronary artery bypass grafting surgery, today provided a business update and announced financial results for its second quarter ended June 27, 2015.
Kips Bay Medical Announces an Orderly Wind Down of Operations With the Termination of eMESH I Clinical Feasibility Trial
GlobeNewswire - Mon Jun 29, 7:49AM CDT
Kips Bay Medical, Inc. (OTCQB:KIPS) today announced its decision to terminate its eMESH I clinical feasibility trial due to poor early angiographic results from enrolled patients who had an eSVS Mesh implanted using the new surgical implant technique and its intention to effect an orderly wind down of its operations.
Kips Bay Medical Provides Clinical Trial Update and Reports First Quarter 2015 Results
GlobeNewswire - Tue May 12, 3:53PM CDT
Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS Mesh, for use in coronary artery bypass grafting surgery, today provided a clinical trial update and announced financial results for its first quarter ended March 28, 2015.
Kips Bay Medical Announces $3.25 Million Private Placement Bridge Financing
GlobeNewswire - Tue Mar 24, 3:37PM CDT
Investors Include Manny Villafana and Kips Bay Investments, LLC
Kips Bay Medical Announces Achievement of Enrollment Goal and Provides Business Update and Fourth Quarter and Full Year 2014 Results
GlobeNewswire - Thu Mar 12, 8:09AM CDT
Manny Villafana, Chairman and Chief Executive Officer of Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS Mesh, for use in coronary artery bypass grafting surgery, today announced that the Company had reached its targeted enrollment goal for its eMESH I clinical feasibility trial and provided a business update and financial results for its fourth quarter and full year ended December 31, 2014.
Kips Bay Medical Reorganizes Operations and Reduces Staff to Focus on Clinical Study Work and Conserve Capital
GlobeNewswire - Mon Jan 05, 11:00AM CST
Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today announced that the Company has reorganized its operations by eliminating staff positions, instituting salary reductions and reducing its non-clinical related operating expenses, in order to conserve its capital while it pursues the completion of its current eMESH I clinical feasibility trial.
Kips Bay Medical Announces the First eSVS Mesh Implant by the Valley Hospital of New Jersey
GlobeNewswire - Tue Nov 11, 8:23AM CST
Manny Villafana, Chairman and CEO of Kips Bay Medical, Inc. (OTCQB:KIPS), announced that on November 4, 2014, cardiac surgeons at The Valley Hospital's Heart and Vascular Institute in Ridgewood, New Jersey, performed their first implant of an eSVS Mesh. This implant was performed as part of the Kips Bay Medical eMESH I clinical feasibility trial currently being conducted for the U.S. Food and Drug Administration (FDA) in a number of preeminent cardiac surgery centers in both Europe and the United States.
Kips Bay Medical Provides Feasibility Study Update and Reports Third Quarter 2014 Results
GlobeNewswire - Thu Nov 06, 8:45AM CST
Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provided a business update and announced financial results for its third quarter ended September 27, 2014.
Kips Bay Medical Provides Clinical and Business Update
GlobeNewswire - Tue Oct 14, 8:00AM CDT
Kips Bay Medical, Inc. (OTCQB:KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today provides an update on its clinical progress and business operations.
